190 related articles for article (PubMed ID: 1769735)
1. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
2. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
[TBL] [Abstract][Full Text] [Related]
3. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
[TBL] [Abstract][Full Text] [Related]
4. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
[TBL] [Abstract][Full Text] [Related]
5. Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients.
Argani H; Rahbaninoubar M; Ghorbanihagjo A; Golmohammadi Z; Rashtchizadeh N
Nephron Clin Pract; 2005; 101(4):c174-9. PubMed ID: 16103722
[TBL] [Abstract][Full Text] [Related]
6. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
[TBL] [Abstract][Full Text] [Related]
7. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
Glöggler A; Bulla M; Fürst P
Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
[TBL] [Abstract][Full Text] [Related]
8. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effect of d,l-carnitine on lipid metabolism of patients after prolonged dialysis].
Król E; Rutkowski B; Manitius J; Manitius A; Sałek J; Wróblewska M; Lysiak-Szydłowska W
Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):614-6. PubMed ID: 1669126
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
Alhomida AS
Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
[TBL] [Abstract][Full Text] [Related]
11. Effect of carnitine on serum HDL-cholesterol: report of two cases.
Rossi CS; Siliprandi N
Johns Hopkins Med J; 1982 Feb; 150(2):51-4. PubMed ID: 7057619
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
13. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
[TBL] [Abstract][Full Text] [Related]
14. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
15. [Behavior of important serum lipid fractions in chronic hemodialysis patients and following kidney transplantation].
Luci V; Wichmann T; Giesselmann M; Koall W; Mampel E
Z Gesamte Inn Med; 1983 Mar; 38(5):153-7. PubMed ID: 6344469
[TBL] [Abstract][Full Text] [Related]
16. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
[TBL] [Abstract][Full Text] [Related]
17. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
[TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
19. Fish oil treatment of hyperlipidemia in children and adolescents receiving renal replacement therapy.
Goren A; Stankiewicz H; Goldstein R; Drukker A
Pediatrics; 1991 Aug; 88(2):265-8. PubMed ID: 1861924
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients.
Suchitra MM; Ashalatha VL; Sailaja E; Rao AM; Reddy VS; Bitla AR; Sivakumar V; Rao PV
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1155-9. PubMed ID: 22089773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
